Insider Trading: Alimera Sciences Inc (ALIM.W)
ALIM.W on CBOE When Trading NASDAQ Global Select Market
4.18USD
17 May 2013
4.18USD
17 May 2013
Price Change (% chg)
$-0.29 (-6.49%)
$-0.29 (-6.49%)
Prev Close
$4.47
$4.47
Open
$3.90
$3.90
Day's High
$4.18
$4.18
Day's Low
$3.90
$3.90
Volume
200
200
Avg. Vol
59
59
52-wk High
$4.95
$4.95
52-wk Low
$1.37
$1.37
| POLARIS VENTURE MANAGEMENT CO IV L L C | Options Exercised: 0 | ||
| Trade Date: | Monday, 10 Oct 2011 | Price: | 0.00 |
| Title: | Beneficial Owner of More than 10% Class | Shares Held: | 4,022,323 |
| Type Traded: | Indirect | Net Change in Shares This Filing: | -297,003 |
Institutional Holders
| % Shares Owned: | 0.00% |
| # of Holders: | 38 |
| Total Shares Held: | 47,163,235 |
| 3 Mo. Net Change: | -262,411 |
| # New Positions: | 3 |
| # Closed Positions: | 12 |
| # Increased Positions: | 7 |
| # Reduced Positions: | 20 |
| # Net Buyers: | -13 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
Philip Tracy |
70 | 2004 | Independent Chairman of the Board |
C. Daniel Myers |
58 | President, Chief Executive Officer, Director | |
Richard Eiswirth |
44 | 2010 | Chief Financial Officer, Chief Operating Officer |
Kenneth Green |
54 | 2007 | Senior Vice President, Chief Scientific Officer |
David Holland |
49 | 2010 | Senior Vice President - Sales and Marketing |
Philip Ashman |
2012 | Senior Vice President, European Managing Director | |
Susan Caballa |
68 | 2004 | Senior Vice President - Regulatory and Medical Affairs |
Garheng Kong |
2012 | Director | |
Glen Bradley |
69 | 2011 | Independent Director |
Mark Brooks |
2004 | Independent Director | |
Brian Halak |
41 | 2004 | Independent Director |
James Largent |
62 | 2011 | Independent Director |
Peter Pizzo |
46 | 2010 | Independent Director |
Calvin Roberts |
60 | 2003 | Independent Director |
John Mills |
IR Contact |

